US FDA approves Mesoblast’s cell therapy for graft-versus-host disease
(Reuters) – The U.S. Food and Drug Administration on Wednesday approved Mesoblast (NASDAQ:MESO)’s cell therapy for treating a type of...
Read more(Reuters) – The U.S. Food and Drug Administration on Wednesday approved Mesoblast (NASDAQ:MESO)’s cell therapy for treating a type of...
Read moreInvesting.com – Canada stocks were lower after the close on Wednesday, as losses in the IT, Materials and Healthcare sectors...
Read more(Reuters) – North American graphite miners asked the U.S. government on Wednesday to impose a tariff as high as 920%...
Read moreInvesting.com – Colombia stocks were lower after the close on Wednesday, as losses in the Financials, Investment and Public Services...
Read moreInvesting.com – Mexico stocks were lower after the close on Wednesday, as losses in the Industrials, Consumer Goods & Services...
Read moreInvesting.com – U.S. stocks were lower after the close on Wednesday, as losses in the Consumer Goods, Financials and Consumer...
Read moreWASHINGTON (Reuters) -The United States issued fresh sanctions on Wednesday on several Russia-based entities over their involvement in the Nord...
Read moreBy Andrew Chung, David Shepardson WASHINGTON (Reuters) -The U.S. Supreme Court decided on Wednesday to hear a bid by TikTok...
Read more(Reuters) – USAA Federal Savings Bank has been ordered to correct a range of longstanding regulatory deficiencies amounting to unsafe...
Read moreBy Alexandra Alper WASHINGTON (Reuters) -Despite a steady stream of meetings and calls with U.S. officials, and three revamped proposals...
Read more